Canadian neuroscience leaders tap IBM Watson to speed time to discovering new drugs for …

By PR Newswire Article Rating: October 12, 2016 09:00 AM EDT   IBM Watson for Drug Discovery chosen to help researchers more rapidly pinpoint promising drug targets TORONTO, Oct. 12, 2016 /CNW/ – IBM (NYSE: IBM) Watson Health today announced that the Ontario Brain Institute (OBI) and the Movement Disorders Clinic (MDC) at Toronto’s University Health Network (UHN) will embark on Canada’s first ever Parkinson’s disease research project using the recently launched IBM Watson for Drug Discovery. MDC researchers, along with members of the Informatics and Analytics team at OBI, will use Watson to accelerate the drug discovery process – transforming how researchers discover new drugs, and determine which drugs could potentially be repurposed in the fight against Parkinson’s disease – far more rapidly than by traditional methods. Drawing from its…


Link to Full Article: Canadian neuroscience leaders tap IBM Watson to speed time to discovering new drugs for …